Net Neutrality - Another Obama era regulatory regime bites
Net Neutrality - Another Obama era regulatory regime bites the dust
< >
The Federal Communications Commission (FCC) will repeal all Obama-era rules relating to "net neutrality." The vote on repeal will be taken in December, when the Republican majority is expected to approve it.
The Obama net neutrality rules hindered innovation and prevented telecoms from charging more for faster internet service. Eventually, net neutrality regulations would have established an internet price structure that had nothing to do with market forces.
Politico:
President Donald Trump-appointed Pai's plan would jettison rules that prohibit internet service providers from blocking or slowing web traffic or creating so-called paid internet fast lanes, the people familiar with the changes said.
Pai also will follow through on his plans to scrap the legal foundation that the FCC's old Democratic majority adopted in 2015 to tighten federal oversight of internet service providers, a move he contends has deterred the industry from investing in broadband networks. Internet providers have feared that legal foundation, if left in place, could set the stage for possible government price regulation of internet service.
The chairman's approach, to be voted on at the FCC's Dec. 14 meeting, would also get rid of the so-called general conduct standard, which gives the FCC authority to police behavior by internet service providers it deems unreasonable.
The plan includes transparency rules that would require internet service providers to inform their customers about their practices on issues such as blocking and throttling. Major internet providers, including Comcast, have publicly said they will not block or throttle web traffic.
The FCC will look to another agency, the Federal Trade Commission, to police whether internet service providers are acting in an anti-competitive manner.
An FCC spokesman declined comment on the plan.
Supporters of the existing rules, including tech giants like Netflix and left-leaning digital activists, say they are necessary to ensuring the internet remains a level playing field. But critics, including Pai, have said they are too burdensome and deter investment in broadband networks.
Supporters of net neutrality say big companies can't be trusted to run the internet fairly for all. This is poppycock. Why should a company look to drive customers away by blocking or "throttling" the internet for them? And the notion that those companies that use the internet more than others shouldn't pay more for a higher speed is anti-competitive.
There were some activists on the right who supported net neutrality. I think they were wrong. Those rules would certainly have stifled innovation and, like many government regulations, interfered with good business practices. Markets need freedom to promote competitiveness, which keeps costs down and encourages technological advances. The Obama-era rules would have done the opposite.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Million-Dollar Waves in Real Estate Tell you what, there’s something electrifying about a $500 million milestone in the real estate game, and when it's all about short term rentals, you know folks are really onto something. The Short Term Shop isn't just flipping houses in Destin, 30A, and Panama City Beach—they're setting benchmarks. It takes more than a fancy suit...
Continue Reading
Revolutionizing Maternity Support at Saddleback Saddleback Medical Center in Laguna Hills, California, is stirring the waters with its groundbreaking expansion in maternity services. For the first time, an Orange County hospital—The Women’s Hospital at MemorialCare Saddleback Medical Center—is offering complimentary, around-the-clock in-house doulas. Not a luxury,...
Continue Reading
Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...
Continue Reading
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
Florida's Ambitious Economic Goals When someone floats the idea of a state's economy cracking the top 10 globally by the year 2030, you've got to wonder if it's all sunshine and rainbows, or if there's some serious groundwork being laid. The Florida Chamber Foundation seems to think it's achievable. As the end of October rolls around, they're throwing the 2026 Future of...
Continue Reading
CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...
Continue Reading
Well, isn’t this just a spicy tidbit from the real estate frontier? Oberndorf Real Estate Management and The Bascom Group are strutting into San Jose with a hefty $53.1 million deal that snags them the Museum Park Apartments. These guys aren't just dipping their toes; they’re cannonballing into the market with style. Now, exactly what does it mean for you and me?...
Continue Reading
MSA Gears Up for Q3 Earnings Call—Why It Matters At the crack of dawn on November 3, 2026, MSA Safety Incorporated (NYSE: MSA) is set to unravel the latest updates on their financial frontline. For those keeping a sharp eye on the safety gear behemoth, this isn’t just another earnings call—it's the kind of event that can make or break confidence in their stock....
Continue Reading
Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...
Continue Reading
Hydrogen Takes Center Stage in Urban Planning Well, I didn't see this one coming—a city that's planning the power before the buildings. We're talking about ELISIUM, the so-called cognitive city destined to rise in Hendry County, Florida. And leading the charge in all this energy planning? None other than VIVIFY Technology, set to bring in its hydrogen expertise right...
Continue Reading
Top 5 Most Recently Viewed Articles
Exciting Developments from Mozart Therapeutics Recent findings from Mozart Therapeutics shine a spotlight on MTX-201, a groundbreaking bispecific antibody designed to treat inflammatory bowel disease (IBD). This innovative therapy selectively binds to CD8 regulatory T cells (Treg), with the potential to effectively eliminate pathogenic CD4 T cells and lessen inflammation,...
Continue Reading
Arixa Capital Achieves New Heights in Loan Originations Arixa Capital, a prominent private real estate lender, has officially crossed the impressive milestone of over $7 billion in total loan originations since its establishment. This remarkable achievement underscores the firm's commitment to providing flexible and reliable financing solutions to real estate...
Continue Reading
Synaffix and Illumina Join Forces for Breakthrough Technologies Synaffix B.V., a prominent biotechnology company renowned for its innovative clinical-stage bioconjugation platform technology, has announced a licensing agreement with Illumina, Inc., a leader in DNA sequencing technologies. This agreement allows Illumina access to Synaffix's patented metal-free click...
Continue Reading
Bristol Myers Squibb Gaining Traction in Colorectal Cancer Treatment Bristol Myers Squibb (NYSE: BMY) has recently secured a significant win by obtaining approval from the European Commission (EC) for its leading immunotherapy combinations. This approval is specifically for the use of Opdivo (nivolumab) combined with Yervoy (ipilimumab) as a first-line treatment option...
Continue Reading
Hillary F. Blackburn's Significant New Role The U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) have made an important announcement. They have appointed Hillary F. Blackburn, PharmD, MBA, as the first pharmacist voting member of the Advisory Committee on Immunization Practices (ACIP). This historic appointment...
Continue Reading